成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

ChemicalBook >> journal list >> Ocular Surface >>article
Ocular Surface

Ocular Surface

IF: 5.9
Download PDF

Benzalkonium Chloride in Glaucoma Medications

Published:1 July 2011 DOI: 10.1016/S1542-0124(11)70025-8 PMID: 21791190
Robert Noecker MD, MBA , Kimberly V. Miller MD

Abstract

Benzalkonium chloride (BAK) is the preservative used most commonly in eye drops. Although it is effective as an antimicrobial and antifungal agent, both in vitro and in vivo studies have demonstrated adverse effects on surface epithelial cell populations. This is of particular concern with regard to topical medications used over long periods for chronic conditions, such as glaucoma. Newer non-BAK-containing drops are becoming increasingly available, providing an alternative for patients needing long-term eye drop therapy.

Substances (2)

Related products
Procduct Name CAS Molecular Formula Supplier Price
Benzalkonium Chloride 63449-41-2 C17H30ClN 579 suppliers $21.00-$2665.00
BENZALKONIUM CHLORIDE 68424-85-1 C17H30ClN 127 suppliers $19.00-$787.00

Similar articles

IF:4.6

Intraocular and intracranial pressure in glaucoma patients taking acetazolamide.

ACS Applied Bio Materials Allison R Loiselle, Emile de Kleine,etc Published: 18 June 2020
IF:5.6

The Latest Evidence of Erythropoietin in the Treatment of Glaucoma.

International Journal of Molecular Sciences Ting-Yi Lin, Yi-Fen Lai,etc Published: 16 December 2022